Pfizer on 5 January 2023 announced a 12-week paternity leave policy for its employees, as part of the firm's diversity and inclusion initiatives.
In a statement released by the brand, they stated that the policy for use is applicable from January 1, 2023 and can be availed by biological as well as adoptive fathers.
According to the drafted policy both the biological and adoptive fathers are allowed to avail leaves over a period of two-year in a maximum of four tranches. However, a single tranche of leaves can be taken for a minimum of two weeks and a maximum of six weeks.
Adding more, the firm said that the employee will be allowed to take additional leaves as permitted by the company's leave policy. This may be casual leave, elective holidays, and wellness days or in the event of any complication.